SOLU-CORTEF

This brand name is authorized in United States. It is also authorized in Australia, Canada, Croatia, Estonia, Finland, Hong Kong SAR China, Ireland, Israel, Japan, Malta, Netherlands, New Zealand, Singapore, South Africa, UK.

Active ingredients

The drug SOLU-CORTEF contains one active pharmaceutical ingredient (API):

1	Hydrocortisone UNII 50LQB69S1Z - HYDROCORTISONE SODIUM SUCCINATE
	Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates.
	Read more about Hydrocortisone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
Solu-Cortef	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H02AB09	Hydrocortisone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1501B, 1510L, 1511M, 3096Y, 3470P, 3471Q, 5118J, 5119K
CA	Health Products and Food Branch	00030600, 00030619, 00030627, 00030635
EE	Ravimiamet	1009066
FI	Lääkealan turvallisuus- ja kehittämiskeskus	439954, 496943, 523273
GB	Medicines & Healthcare Products Regulatory Agency	138713, 41828
HK	Department of Health Drug Office	00471, 25551
HR	Agencija za lijekove i medicinske proizvode	HR-H-226141869
IE	Health Products Regulatory Authority	46612
IL	מִשְׂרַד הַבְּרִיאוּת	8129, 8219
JP	医薬品医療機器総合機構	2452400D3052, 2452400D6060, 2452400D7040
MT	Medicines Authority	AA565/67101
NL	Z-Index G-Standaard	14043912
NL	Z-Index G-Standaard, PRK	20400
NZ	Medicines and Medical Devices Safety Authority	1672
SG	Health Sciences Authority	04791P
US	FDA, National Drug Code	0009-0005, 0009-0011, 0009-0013, 0009-0016, 0009-0825, 51662-1261, 51662-1262, 55154-3942
ZA	Health Products Regulatory Authority	G/21.5/201